首页|期刊导航|临床误诊误治|某肿瘤医院ICU患者耐碳青霉烯鲍曼不动杆菌感染的危险因素及其耐药性分析

某肿瘤医院ICU患者耐碳青霉烯鲍曼不动杆菌感染的危险因素及其耐药性分析OA

Analysis of risk factors and drug resistance of carbapenem-resistant Acinetobacter baumannii infection in ICU patients of a cancer hospital

中文摘要英文摘要

目的 分析某肿瘤医院重症监护室(ICU)患者耐碳青霉烯鲍曼不动杆菌(CRAB)感染的危险因素及其耐药性.方法 回顾性收集2022-2024年山西省肿瘤医院ICU收治的372例经细菌培养鉴定为鲍曼不动杆菌感染患者的临床资料,并根据碳青霉烯类药物敏感试验结果分为CRAB组与非CRAB组.采用单因素分析筛选潜在危险因素,进一步多因素Logistic回归确定影响ICU患者CRAB感染的独立危险因素,随后统计分析ICU患者CRAB标本来源分布情况以及对常见抗菌药物的耐药性.结果 ICU患者中,CRAB检出率为80.38%(299/372),CRAB菌株标本主要来源于痰液占69.57%(208/299),其次为引流液占14.72%(44/299)、血液占12.37%(37/299)、尿液占3.34%(10/299).合并两种及以上基础疾病、入ICU时急性生理学和慢性健康状况评价Ⅱ评分≥20分、深静脉置管、气管插管或切开、导尿管留置、机械通气时间≥7 d、抗菌药物使用时间≥7 d、使用碳青霉烯类抗生素、抗菌药物使用种类≥2种均为影响ICU患者CRAB感染的独立危险因素(P<0.01).ICU患者分离的CRAB菌株对多种常用抗菌药物的耐药率均超过85.00%,其中亚胺培南、美罗培南耐药率为100.00%;对替加环素、多黏菌素、阿米卡星的耐药率分别为13.38%、18.06%、57.19%.非CRAB菌株对包括碳青霉烯类在内的多数抗菌药物保持高度敏感,尤其对亚胺培南和美罗培南完全敏感,对替加环素、多黏菌素、阿米卡星也表现出较高的敏感性.结论 ICU患者CRAB感染菌株标本主要来源于痰液,其感染发生受上述多种因素影响.CRAB菌株对替加环素、多黏菌素保持较高敏感性,但对大部分常用抗菌药物具有较高的耐药率.

Objective To analyze the risk factors and drug resistance of carbapenem-resistant Acinetobacter baumannii(CRAB)infection in ICU patients of a cancer hospital.Methods The clinical data of 372 patients with Acinetobacter baumannii(A.baumannii)infection,identified through bacterial culture at the ICU of Shanxi Cancer Hospital from 2022 to 2024,were retrospectively collected.These patients were divided into the CRAB group and the non-CRAB group based on the results of carbapenem sensitivity tests.Univariate analysis was used to screen potential risk factors,and further multivariate logistic regression was employed to determine the independent risk factors for CRAB infection in ICU patients.Subsequently,the distribution of specimen sources of CRAB in ICU patients and the drug resistance to common antibacterial drugs were statistically analyzed.Results Among ICU patients,the detection rate of CRAB was 80.38%(299/372).The main source of CRAB strain specimens was sputum,accounting for 69.57%(208/299),followed by drainage fluid at 14.72%(44/299),blood at 12.37%(37/299),and urine at 3.34%(10/299).Presence of two or more underlying diseases,an Acute Physiology and Chronic Health Evaluation Ⅱ(APACHEⅡ)score of≥20 at ICU admission,deep vein catheterization,tracheal intubation or incision,indwelling urinary catheter,mechanical ventilation time of≥7 d,duration of antibiotic use of≥7 d,use of carbapenem antibiotics,and use of≥2 types of antibiotics were all independent risk factors affecting CRAB infection in ICU patients(P<0.01).The resistance rate of CRAB strains isolated from ICU patients to various commonly used antibiotics exceeded 85.00%.Among them,the resistance rates to Imipenem and Meropenem were 100.00%;the resistance rates to Tigecycline,Polymyxin,and Amikacin were 13.38%,18.06%,and 57.19%,respectively.Non-CRAB strains remained highly sensitive to most antibiotics,especially Imipenem and Meropenem,which were completely sensitive,and showed high sensitivity to Tigecycline,Polymyxin,and Amikacin.Conclusion The specimens of CRAB infection strains in ICU patients mainly come from sputum.The occurrence of infection is influenced by various factors mentioned above.The CRAB strains show high sensitivity to Tigecycline and Polymyxins,but have a high resistance rate to most commonly used antibacterial drugs.

白玲;贾晓云

山西省肿瘤医院 中国医学科学院肿瘤医院山西医院 山西医科大学附属肿瘤医院感染管理科,太原 030013山西医科大学第二医院医疗保健中心,太原 030001

重症监护病房肿瘤患者耐碳青霉烯鲍曼不动杆菌感染耐药性危险因素

intensive care unittumour patientscarbapenem-resistant Acinetobacter baumanniiinfectiondrug resistancerisk factors

《临床误诊误治》 2026 (11)

32-38,7

山西省卫生健康委员会重点科技攻关专项(2025ZD035)

10.3969/j.issn.1002-3429.2026.11.006

评论